Studies from our laboratory suggested that regulation of the growth of hormone-dependent mammary tumors may depend on the antagonistic action between estrogen and cyclic AMP (CAMP). Estrogen stimulates whereas cAMP arrests the growth of mammary carcinomas induced by 7,12-dimethylbenz(a)anthracine (DMBA) in the rat (Cho-Chung and Gullino, 1974). During growth arrest of the tumors after either hormone removal (ovariectomy) or treatment of the hosts with N6, d'-dibutyryl-CAMP (DBcAMP), estrogen binding decreases whereas cAMP binding and CAMP-dependent protein kinase activity increase in the cytosol and nuclei of the tumor cells (Bodwin et al., 1978). It was further demonstrated that the growth of DMBA-induced mammary tumors is associated with an enhanced expression of a cellular oncogene, c-rasH, The p21-transforming protein of the ras gene product (Shih et al., 1979) was a predominant in vitro translation product of mRNAs of the growing tumors, and a sharp reduction of the translated p2 1 protein preceded regression of these tumors after either ovariectomy or DBcAMP treatment (Huang and Cho-Chung, 1984).Recent studies on cAMP binding kinetics, using purified preparations of CAMP-dependent protein kinases, identified cAMP analogues that are potent activators of protein kinase and selectively bind to either one of the 2 different cAMP binding sites (Rannels and Corbin, 1980) of protein kinase. Generally, analogues modified at the C-8 position of adenine ring are Site 1-selective and those modified at the C-6 position are Site 2-selective (Rannels and Corbin, 1980). Furthermore, the Site 1-and Site 2-selective analogues in combination demonstrate synergism of binding to and activation of protein kinase (Robinson-Steiner and Corbin, 1983; Qgreid et al., 1985). the effect of site-selective cAMP analogues on the growth and cellular proto-oncogene expression that can be stimulated by estrogen in human MCF-7 breast-cancer cells.
MATERIAL AND METHODS
MaterialCAMP, DBcAMP, and 8-bromo-CAMP were from Boehringer Mannheim (Indianapolis, IN). N6-monobutyryl CAMP, N6-benzoyl CAMP, and 17P-esrradiol were obtained from Sigma (St. Louis, MO). All other cAMP analogues were provided by Dr. R.K. Robins (Revankar and Robins, 1982). Tamoxifen (ICI-46474) was obtained from Stuart (Wilmington, DE). Improved minimal essential medium (IMEM) was obtained from NIH Media and Glassware Section. Dulbecco's phosphate-buffered saline (PBS), fetal bovine serum (FBS), trypsin-EDTA solution, penicillin-streptomycin solution, Lglutamine, and N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer 1 M stock solution, PH 7.3, were obtained from GIBCO (Grand Island, NY). The MCF-7 breastcancer cell line was provided by Dr. M. Lippman.
Cell cultureMCF-7 cells were grown in IMEM with no phenol red (Berthois et al., 1986), containing 6.5 % of charcoal-stripped serum, HEPES 20 mM, penicillin-streptomycin, and extra glutamine. Cells were grown at 37°C in humidified incubators in an atmosphere of 5 % C02.For cell growth experiments, 1-2 X lo5 cells/...